FDA Import Refusal 799-5160378-6/11/1 — Abbvie Biotechnology Gmbh
The FDA refused shipment 799-5160378-6/11/1 from Abbvie Biotechnology Gmbh (Germany) on Jun 7, 2023. The refused product falls under Drugs and Biologics — ADALIMUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 7, 2023
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61YCY02 ADALIMUMAB
- Charges
- 75